Dr David Prim

David Prim, PhD, is a Principal at Broadview Ventures, where he shares responsibility for investment activities in support of The Leducq Charitable Trust’s mission to improve human health in cardiovascular disease and stroke. David’s responsibilities include identification and screening of new opportunities, due diligence, negotiation of deal structure, and portfolio company board involvement. He currently serves on the Board of Directors for CorFlow Therapeutics, Relief Cardiovascular, Puzzle Medical Devices, and RUA Structural Heart.

Prior to joining Broadview, David was a Senior Associate at Locust Walk, a global life sciences transaction firm, where he led engagements for biopharma and medtech clients guiding corporate development strategy and supporting sell-side, buy-side, and financing deal execution. Previously, David was a consultant at ClearView Healthcare Partners, a premier life science strategy consulting firm, where he supported completion of high-impact strategy projects for a broad range of industry clients across all aspects of the product lifecycle, including new product planning, R&D, commercial, medical affairs, market access, and lifecycle management.

David earned a PhD in Biomedical Engineering from the University of South Carolina, where his research focused on cardiovascular disease. His research projects covered a wide range of vascular mechanics, hemodynamics, and tissue engineering, with a specific focus on understanding and improving remodeling of coronary artery bypass grafts. David also holds a BS in Biomedical Engineering from USC with honors from the South Carolina Honors College.